Authors:
Gerber, JG
Rosenkranz, S
Segal, Y
Aberg, J
D'Amico, R
Mildvan, D
Gulick, R
Hughes, V
Flexner, C
Aweeka, F
Hsu, A
Gal, J
Citation: Jg. Gerber et al., Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401, J ACQ IMM D, 27(2), 2001, pp. 153-160
Authors:
Rousseau, FS
Kahn, JO
Thompson, M
Mildvan, D
Shepp, D
Sommadossi, JP
Delehanty, J
Simpson, JN
Wang, LH
Quinn, JB
Wakeford, C
van der Horst, C
Citation: Fs. Rousseau et al., Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil), J ANTIMICRO, 48(4), 2001, pp. 507-513
Authors:
Babiker, A
Bartlett, J
Breckenridge, A
Collins, G
Coombs, R
Cooper, D
Creagh, T
Cross, A
Daniels, M
Darbyshire, J
Dawson, D
DeGruttola, V
DeMasi, R
Dolin, R
Eron, J
Fischl, M
Grossberg, S
Hamilton, J
Hammer, S
Hartigan, P
Henry, K
Hill, A
Hughes, M
Kahn, J
Katlama, C
Katzenstein, D
Kim, S
Mildvan, D
Montaner, J
Moore, M
Neaton, J
O'Brien, W
Ribaudo, H
Richman, D
Saag, M
Salgo, M
Saravolatz, L
Schooley, R
Seligmann, M
Staszewski, S
Struthers, L
Tierney, C
Tsiatis, A
Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
Authors:
Zackin, RA
Clark, RA
Currier, JS
Mildvan, D
Citation: Ra. Zackin et al., Predictive markers of HIV-related weight loss and determination of differences between populations with weight loss stratified by opportunistic processes, J ACQ IMM D, 22(2), 1999, pp. 189-193